Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00591526 | A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL) | completed | Phase 3 | 250 | Groupe d'etude et de travail sur les leucemies aigues promyelocytairesOTHER | 0 | Jan 14, 2008 | clinicaltrials |
| NCT00040092 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | completed | Phase 3 | 400 | Aptose Biosciences Inc.INDUSTRY | 0 | Jan 7, 2008 |
| clinicaltrials |
| NCT00165087 | Treatment of Childhood Acute Lymphoblastic Leukemia | terminated | Phase 3 | 491 | Dana-Farber Cancer InstituteOTHER | 3 | Dec 28, 2007 | clinicaltrials |
| NCT00050375 | Clinical Trial for Ovarian Cancer (OvaRex®) | terminated | Phase 3 | 354 | Unither PharmaceuticalsINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00234429 | A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma | completed | Phase 2 / Phase 3 | 74 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00252707 | Iressa 2nd Line Phase III Study in Japan | completed | Phase 3 | 484 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00575926 | Lingzhi for Cancer Children | completed | Phase 3 | 58 | Chinese University of Hong KongOTHER | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00215007 | Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT) | unknown | Phase 2 / Phase 3 | — | Charite University, Berlin, GermanyOTHER | 1 | Nov 30, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | unknown | Phase 3 | 1,200 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 19, 2007 | clinicaltrials |
| NCT00559351 | RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | terminated | Phase 3 | 84 | Ministry of Scientific Research and Information Technology, PolandOTHER_GOV | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00128531 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | completed | Phase 3 | 120 | GP-PharmINDUSTRY | 9 | Nov 14, 2007 | clinicaltrials |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | completed | Phase 3 | 242 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00273338 | DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | terminated | Phase 3 | 1,200 | NovaceaINDUSTRY | 9 | Nov 6, 2007 | clinicaltrials |
| NCT00554125 | Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00047632 | Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer | terminated | Phase 3 | 847 | InterMuneINDUSTRY | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00316745 | IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer | suspended | Phase 3 | 200 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00535912 | Phase III Study Treatment of CLL B and C | completed | Phase 3 | 140 | French Innovative Leukemia OrganisationOTHER | 0 | Nov 1, 2007 | clinicaltrials |
| NCT00536393 | Treatment of Disseminated High Grade Lymphoma | completed | Phase 2 / Phase 3 | 100 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00536458 | Treatment of Localized Low Grade Lymphomas | completed | Phase 3 | 132 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00460681 | Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00548600 | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate | completed | Phase 3 | 112 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00546988 | Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years | unknown | Phase 3 | 600 | University of WuerzburgOTHER | 2 | Oct 19, 2007 | clinicaltrials |
| NCT00201942 | PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | completed | Phase 3 | 336 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 18, 2007 | clinicaltrials |
| NCT00297570 | Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy | unknown | Phase 3 | 90 | Sheba Medical CenterOTHER_GOV | 1 | Oct 10, 2007 | clinicaltrials |
| NCT00421694 | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | completed | Phase 2 / Phase 3 | 119 | University of L'AquilaOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00539630 | TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN | completed | Phase 3 | 86 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00142571 | Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma | completed | Phase 3 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2007 | clinicaltrials |
| NCT00001561 | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation | completed | Phase 3 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 24, 2007 | clinicaltrials |
| NCT00533299 | Hydralazine Valproate for Ovarian Cancer | unknown | Phase 3 | 211 | National Institute of CancerologíaOTHER_GOV | 1 | Sep 21, 2007 | clinicaltrials |
| NCT00181012 | Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics | unknown | Phase 3 | 100 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 19, 2007 | clinicaltrials |
| NCT00529412 | Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction | completed | Phase 3 | 150 | Nihon UniversityOTHER | 1 | Sep 14, 2007 | clinicaltrials |
| NCT00041626 | Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone | unknown | Phase 3 | — | Introgen TherapeuticsINDUSTRY | 1 | Sep 11, 2007 | clinicaltrials |
| NCT00525967 | Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain | unknown | Phase 2 / Phase 3 | 50 | Faculdade de Medicina do ABCOTHER | 1 | Sep 6, 2007 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
| NCT00517712 | Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia(IAPLSG04) | unknown | Phase 2 / Phase 3 | 400 | Christian Medical College, Vellore, IndiaOTHER | 1 | Aug 17, 2007 | clinicaltrials |
| NCT00162721 | The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas | unknown | Phase 3 | 270 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00514488 | Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)(CML022) | completed | Phase 3 | — | University of BolognaOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00164879 | Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers | unknown | Phase 3 | 70 | Chinese University of Hong KongOTHER | 1 | Aug 7, 2007 | clinicaltrials |
| NCT00145652 | Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. | completed | Phase 3 | 66 | Sundsvall HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00169130 | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | completed | Phase 2 / Phase 3 | 300 | Lymphoma Study AssociationOTHER | 2 | Jul 13, 2007 | clinicaltrials |
| NCT00294151 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | unknown | Phase 3 | 30 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00136552 | Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden | completed | Phase 3 | 360 | Lymphoma Study AssociationOTHER | 2 | Jul 3, 2007 | clinicaltrials |
| NCT00201929 | A Decision Aid for Women With Early Stage Breast Cancer | completed | Phase 3 | 300 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00494039 | I-125 Versus Pd-103 for Low Risk Prostate Cancer | unknown | Phase 3 | 602 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00494546 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | completed | Phase 3 | 568 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00344526 | Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis | completed | Phase 3 | 100 | University Hospital, LimogesOTHER | 1 | Jun 28, 2007 | clinicaltrials |
| NCT00486460 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | unknown | Phase 3 | — | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00486499 | I-125 Versus Pd-103 for Medium Risk Prostate Cancer | unknown | Phase 3 | 660 | VA Puget Sound Health Care SystemFED | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00243204 | Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Jan 14, 2008source: clinicaltrials